搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
1 小时
DR ELLIE: Here's how to get an Ozempic from your GP
I am 68, overweight and my blood pressure is high. Since the menopause, I've been exhausted. I've read about the benefits of ...
TAG24 NEWS on MSN
3 小时
The winding, fitful path to the wildly popular weight loss drug Ozempic
Together with Habener and others, she proved this theory through lab experiments and human trials, identifying its ...
devdiscourse
6 小时
Major Updates in Health: Drug Approvals, Legal Battles, and Health Innovations
Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...
7 小时
Does Ozempic work for long-term weight loss? New study says yes
Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...
WSGW
9 小时
Inside the thriving market for alternatives to brand-name weight loss drugs
There is no FDA-approved generic version of brand-name weight loss drugs since pharmaceutical companies still hold patents on ...
9 小时
Does ‘nature’s Ozempic’ really work? Trendy GLP-1 supplements are designed to ...
Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...
13 小时
How Ozempic Works—and What’s Still a Mystery
Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...
15 小时
Lizzo Claps Back at Ozempic Rumors After ‘5 Months of Weight Training and Calorie Deficit’
Lizzo is proud of her weight loss progress, which she denied was the result of using Ozempic. “When you finally get Ozempic ...
15 小时
Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects
Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...
18 小时
Eli Lilly: Sticking With A $1000 Target Ahead Of Q3 Earnings, New Trading Range
Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...
devdiscourse
20 小时
Latest Health Developments: Key Approvals and Controversies
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈